GAS6-based CAR-T cells exhibit potent antitumor activity against pancreatic cancer.

"Declarations Ethics approval and consent to participateThe human blood and pancreatic tumor sample collection procedures were carried out after written informed consent and approved by the Institutional Review Board at West China Hospital, Sichuan University (ID: 2022151). All animal experiments in this study were approved by the Animal Ethics Committee of West China Hospital, Sichuan University (ID: 20211492A). Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

"Funding This work was supported by the National Natural Science Foundation of China (82172701 to X Zhao) and the 1·3·5 project for disciplines of excellence, West China Hospital, Sichuan University (ZYYC20002 to X Zhao)."